Combating psychosis in Parkinson’s disease patients: the use of antipsychotic drugs
- 21 March 2006
- journal article
- review article
- Published by Informa Healthcare in Expert Opinion on Investigational Drugs
- Vol. 15 (4) , 339-349
- https://doi.org/10.1517/13543784.15.4.339
Abstract
(2006). Combating psychosis in Parkinson’s disease patients: the use of antipsychotic drugs. Expert Opinion on Investigational Drugs: Vol. 15, No. 4, pp. 339-349. doi: 10.1517/13543784.15.4.339Keywords
This publication has 104 references indexed in Scilit:
- Increased mortality among elderly patients with dementia using atypical antipsychoticsCMAJ : Canadian Medical Association Journal, 2005
- More on repetitive behaviors in Parkinson's diseaseMovement Disorders, 2005
- Antiparkinsonian medication is not a risk factor for the development of hallucinations in Parkinson?s diseaseJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 2004
- Schizophrenia, the metabolic syndrome and diabetesDiabetic Medicine, 2004
- Long‐term outcome of quetiapine use for psychosis among parkinsonian patientsMovement Disorders, 2003
- Treatment of Psychosis in Parkinson???s DiseaseDrug Safety, 2003
- Neuroleptic malignant syndrome induced by atypical antipsychoticsExpert Opinion on Drug Safety, 2003
- Drugs to treat dementia and psychosisMovement Disorders, 2002
- Donepezil in the treatment of hallucinations and delusions in Parkinson’s diseaseNeurological Sciences, 2002
- Cholinergic Rebound and Rapid Onset Psychosis Following Abrupt Clozapine WithdrawalSchizophrenia Bulletin, 1996